Press

Press releases

Current press releases

In this section you can find press releases on current developments, events and topics relevant to URSAPHARM Arzneimittel GmbH. If you have any questions or require additional information about our company, please get in touch with our press contact.

URSAPHARM provides holistic therapy concept for healthy eyelids

Saarbrücken, September 24, 2024. The pharmaceutical manufacturer URSAPHARM has expanded its “concept for healthy eyelids”. The comprehensive and coordinated therapeutic approach for the individual treatment and care of lid margin inflammation (blepharitis) and meibomian gland dysfunction has been complemented by the product EvoTears® OMEGA eye drops. The extended treatment concept includes products for heat treatment, […]

Find out more

New design, easier handling – URSAPHARM relaunches POSIFORLID® eye mask

Saarbrücken, July 9, 2024. New design, easier handling – URSAPHARM relaunches POSIFORLID® eye mask for the treatment of blepharitis and dysfunction of the glands of the eyelids. The pharmaceutical manufacturer URSAPHARM has revised the POSIFORLID® eye mask – the medical device has a new design and is easier to use. The contents of the self-heating […]

Find out more

URSAPHARM Arzneimittel GmbH turns 50

Saarbrücken, 8. April 2024. Celebrating half a century of innovation: URSAPHARM Arzneimittel turns 50 URSAPHARM’s company story began in 1974 and is inextricably linked with healthcare in Saarland. In the 1970s, four pharmacists named Albrecht Holzer, Dieter Trox, Werner Buxmann and Werner Bernhard realised that there was a need to treat eye disease in Saarland population, […]

Find out more

URSAPHARM becomes partner of FIS Ski Jumping World Cup

Saarbrücken, 24 November 2023.  FIS is pleased to announce that URSAPHARM Arzneimittel GmbH and its premium brand HYLO® will join the FIS Ski Jumping World Cup family as its presenting partner through the 2023-2025 seasons. The HYLO® product family is Germany’s market leader for eye drops and ointments to alleviate the symptoms of dry eyes. […]

Find out more

URSAPHARM extends POSIFORLID® portfolio with eyelid hygiene wipes

Saarbrücken, 25 April 2022. Saarbrücken-based pharmaceutical company URSAPHARM is extending its POSIFORLID® product portfolio with eyelid hygiene wipes for treating …

Find out more

New Partnership Expands Scope’s Dry Eye Portfolio with the launch of the OPTASE® HYLO® range of dry eye products in the USA from June 2021.

New York, N.Y. – May 17, 2021 – Scope Eyecare and URSAPHARM Arzneimittel GmbH have been partners collaborating in the European dry eye sector for nearly 12 years. An exciting new partnership for the US paves the way for the next phase of this partnership with the creation and launch of a co-branded range of […]

Find out more

德国海露®全新包装中国上市

HYLO COMOD® is the star product of HYLO® product range. It was launched in Germany in 1999 and since years HYLO COMOD® is the market leading eye care product in Germany and Europe. For more than 20 years, we insist on production in German and supply to the World, and now sell well in 74 […]

Find out more

Superior quality from URSAPHARM – made in Germany

URSAPHARM Arzneimittel GmbH is an internationally active medium-sized pharmaceutical company which has established itself as a market leader in Germany thanks to its wide range of products in the field of ophthalmology, in particular in the eye lubrication sector. Since it was established in 1974, URSAPHARM has guaranteed the consistent translation of innovative pharmaceutical concepts […]

Find out more

Care and relief for the eyes – URSAPHARM becomes the EYE CARE partner for FC Bayern Munich

As part of an extensive partnership, URSAPHARM Arzneimittel GmbH and FC Bayern Mu-nich are declaring war on the lifestyle disease known as “dry eye” and raising awareness about the need for proper eye care. Central to this collaboration is a large-scale, eye-catching campaign in which the top stars from the German record champions take centre […]

Find out more

We use a cookie-less web analysis tool (etracker). For more information and to opt-out, please click here.